@ARTICLE{
author={Tiede Andreas,Rosa Cid Ana,Goldmann Georg,Jimenez-Yuste Victor,Pluta Michael,Lissitchkov Toshko,May Marcus,Matytsina Irina,Miljic Predrag S,Pabinger Ingrid,Persson Paula},
year={2020},
title={Body Mass Index Best Predicts Recovery of Recombinant Factor VIII in Underweight to Obese Patients with Severe Haemophilia A},
journal={THROMBOSIS AND HAEMOSTASIS},
volume={120},
number={2},
pages={277-288},
document_type={Article},
} 

@ARTICLE{
author={Tiede Andreas,Goldmann Georg,Miljic Predrag S,Korsholm Lars,Matytsina Irina,Persson Paula,Jelev Lissitchkov Toshko},
year={2018},
title={A New Dosing Model Based on Body Mass Index to Guide Factor VIII Dosing in Patients with Hemophilia A},
journal={BLOOD},
volume={132},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Lentz Steven R,Janic Dragana M,Kavakli Kaan,Miljic Predrag S,Oldenburg Johannes,Ozelo Margareth Castro,Santagostino Elena,Suzuki Takashi,Zupancic-Salek Silva,Korsholm Lars,Matytsina Irina,Tiede Andreas},
year={2018},
title={Long-term safety and efficacy of turoctocog alfa in prophylaxis and treatment of bleeding episodes in severe haemophilia A: Final results from the guardian 2 extension trial},
journal={HAEMOPHILIA},
volume={24},
number={6},
pages={E391-E394},
document_type={Article},
} 

@ARTICLE{
author={Tiede Andreas,Janic Dragana M,Ozelo M,Santagostino E,Korsholm Lars,Matytsina Irina,Lentz SR},
year={2018},
title={Use of turoctocog alfa for less-frequent prophylaxis in selected patients has comparable efficacy with the overall prophylaxis cohort in Guardian (TM) 2},
journal={HAEMOPHILIA},
volume={24},
number={},
pages={52-52},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Santagostino E,Martin Salces M,Lejniece Sandra,Janic Dragana M,Tripkovic N,Matytsina Irina},
year={2017},
title={Spontaneous Bleeding Rate On Turoctocog Alfa Prophylaxis in a Large Cohort of Patients With Haemophilia A Followed For up to 5 Years - Trends Over Time and Across Geography},
journal={HAEMOPHILIA},
volume={23},
number={},
pages={56-57},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Lentz SR,Cerqueira MH,Janic Dragana M,Kempton CL,Matytsina Irina,Misgav M,Oldenburg J,Ozelo M,Recht M,Rosholm A,Savic Aleksandar D,Suzuki Takashi,Tiede Andreas,Santagostino E},
year={2016},
title={Interim results from a large multinational extension trial (guardian (TM) 2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A},
journal={HAEMOPHILIA},
volume={22},
number={5},
pages={E445-E449},
document_type={Letter},
} 

@ARTICLE{
author={Janic Dragana M,Karim Faraizah Abdul,Matytsina Irina,Ozelo Margareth Castro,Savic Aleksandar D,Tiede Andreas,Oldenburg Johannes},
year={2016},
title={Efficacy and safety of turoctocog alfa for prophylaxis and treatment of bleeding episodes in patients with severe hemophilia A: results from the guardian (TM) 2 trial},
journal={HAEMOPHILIA},
volume={22},
number={},
pages={48-48},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Mancuso ME,Ozelo M,Janic Dragana M,Matytsina Irina,Landorph Andrea,Zeuthan Niels,Roveda A,Pellegrino G},
year={2015},
title={Changes in Annualized Bleeding Rate Over Time and Relationship with Dosing of Tutoctocog a During the Guardian Program},
journal={HAEMATOLOGICA},
volume={100},
number={},
pages={65-66},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Lentz SR,Kempton CL,Janic Dragana M,Savic Aleksandar D,Cerqueira MH,Ozelo MC,Recht M,Oldenburg J,Tiede Andreas,Suzuki Takashi,Matytsina Irina,Zeuthen N,Santagostino E},
year={2015},
title={Interim results from a large multinational extension trial (Guardian TM2) using turoctocog alfa for prophylaxis and treatment of bleeding in patients with severe haemophilia A},
journal={JOURNAL OF THROMBOSIS AND HAEMOSTASIS},
volume={13},
number={},
pages={842-842},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Laguna P,Savic Aleksandar D,Matytsina Irina,Zeuthen N},
year={2015},
title={Prior Treatment Regimen Influences Annualised Bleeding Rate During Long- Term Prophylaxis With Turoctocog Alfa: Experiences From Multinational Trials},
journal={HAEMOPHILIA},
volume={21},
number={},
pages={49-49},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Matytsina Irina,Janic Dragana M,Lejniece Sandra,Santagostino E},
year={2015},
title={Safety of Turoctocog Alfa for The Prevention and Treatment of Bleeds in Patients with Haemophilia A: Results for The Guardian (TM) Clinical Trials},
journal={HAEMOPHILIA},
volume={21},
number={},
pages={33-33},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Santagostino E,Lentz SR,Misgav M,Brand B,Chowdary Pratima,Savic Aleksandar D,Kilinc Yurdanur,Amit Y,Amendola A,Solimeno LP,Saugstrup T,Matytsina Irina},
year={2015},
title={Safety and efficacy of turoctocog alfa (NovoEight (R)) during surgery in patients with haemophilia A: results from the multinational guardian (TM) clinical trials},
journal={HAEMOPHILIA},
volume={21},
number={1},
pages={34-40},
document_type={Article},
} 

@ARTICLE{
author={Ozelo Margareth Castro,Janic Dragana M,Matytsina Irina,Landorph Andrea,Zeuthan Niels,Santagostino Elena},
year={2014},
title={Changes in Annualized Bleeding Rate over Time and Relationship with Dosing of Turoctocog Alfa during the guardian(TM) Program},
journal={BLOOD},
volume={124},
number={21},
pages={-},
document_type={Meeting Abstract},
}